Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
Your fast track to the ultramodern lab
Your fast track to the ultramodern lab
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
Your fast track to the ultramodern lab
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
Your fast track to the ultramodern lab
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
How can an ultramodern laboratory, 100% specialized in uropathology, benefit you and your patients?
Welcome to our booth at Urologidagarna in Malmö, October 5–7. Let’s talk about how you can get visual and intuitive pathology reports within 5 days with high and consistent quality, created by world-leading AI in collaboration with experienced uropathologists.
Your patient, our priority
Urologidagarna i Malmö, booth #43
Malmö Live
October 5–7, 2022
Malmö Live
October 5–7, 2022
Learn more about Inify Laboratories
Watch the video presentation
One out of seven will be diagnosed with prostate cancer
Handling of prostate biopsies makes up an increasing amount of workload for today’s pathology labs. Here, powerful decision support tools – such as Inify Prostate – have the potential to save valuable time for the pathologist, while ensuring a more objective, consistent and accurate evaluation of the biopsies.
PANEL TALK
Inify’s first lab now open! Panel talk Q2 report 2023
Inify Laboratories successfully launched their laboratory in Q2 2023, at the same time delivering their first prostate cancer diagnosis. In this panel discussion, CEO Fredrik Palm and Laboratory Manager Emelie Edvigsson review the company’s success factors so far, as well as what lies ahead. They discuss the interdisciplinary team, the in-house Laboratory Information System (LIS) and the strategic partnerships Inify has entered.
PANEL TALK
Successful first months of laboratory operation: Panel talk Q3 report 2023
Inify’s Q3 report is published and highlights continuous diagnostic operation and very positive feedback from customers. Inify’s CEO Fredrik Palm and Chief Medical Officer Claes Lindh talks about what this means for patients in practice in this panel talk together with Ole Eikeland.
-
Investor News
News
Finansavisen highlights Inify Laboratories
2023-07-03